The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

1. Impact of medical therapy for hormone-secreting Pituitary tumors on bone.Pituitary · 2024
   Review
2. Metabolic effects of prolactin.Frontiers in endocrinology · 2022
   Review
3. Update on vertebral fractures in pituitary diseases: from research to clinical practice.Hormones (Athens, Greece) · 2021
   Review
4. Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.Scientific reports · 2021
   Article
5. Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.Endocrinology and metabolism clinics of North America · 2021
   Review
6. Prolactinomas and menopause: any changes in management?Pituitary · 2020
   Review
7. Management of prolactinoma: a survey of endocrinologists in China.Endocrine connections · 2018
   Article
8. Management of prolactinomas: a survey of physicians from the Middle East and North Africa.Pituitary · 2017
   Article
9. [Prolactin-secreting microadenoma in menopausal women].The Pan African medical journal · 2017
   Article
10. Prolactinomas: evolution after menopause.Archives of endocrinology and metabolism · 2016
    Article
11. Surgical treatment of prolactinomas: cons.Endocrine · 2014
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as